Literature DB >> 16964608

Analysis of pancreatic endocrine development in GDF11-deficient mice.

Darwin S Dichmann1, Hani Yassin, Palle Serup.   

Abstract

Here, we examine the role of GDF11 in pancreatic development. Using in situ hybridization and reverse transcriptase-polymerase chain reaction analyses, we show that Gdf11 transcripts are expressed in embryonic pancreas epithelium before the secondary transition but decrease rapidly afterward. To determine the function of GDF11 during pancreas development, we analyzed Gdf11(-/-) mouse embryos. In such embryos, pancreas size is twofold reduced at embryonic day (E) 18 compared with wild-type littermates. Quantification of the different tissue compartments shows a specific hypoplasia of the exocrine compartment, while the endocrine and ductal compartments are unaffected. Notably, NGN3(+) endocrine precursor cells are increased fourfold at E18, although the amount of endocrine cells in the pancreas of these animals is unchanged compared with wild-type littermates. Similarly, the maturation of endocrine cells as well as the ratio between alpha- and beta-cells appears normal. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964608     DOI: 10.1002/dvdy.20953

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  33 in total

1.  Growth/differentiation factor-11: an evolutionary conserved growth factor in vertebrates.

Authors:  Bruria Funkenstein; Elena Olekh
Journal:  Dev Genes Evol       Date:  2010-08-07       Impact factor: 0.900

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

4.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

Review 5.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

6.  Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra.

Authors:  Zicong Li; Miyuri Kawasumi; Baoping Zhao; Stefan Moisyadi; Jinzeng Yang
Journal:  Mol Reprod Dev       Date:  2010-11       Impact factor: 2.609

7.  Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2.

Authors:  Yun-Sil Lee; Se-Jin Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

Review 8.  Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy.

Authors:  Tingxia Guo; Matthias Hebrok
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

9.  Redundancy of myostatin and growth/differentiation factor 11 function.

Authors:  Alexandra C McPherron; Thanh V Huynh; Se-Jin Lee
Journal:  BMC Dev Biol       Date:  2009-03-19       Impact factor: 1.978

10.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.